Cryptocurrency
Bitcoin hashrate drops as miners shift to AI
Bitcoin’s hashrate has declined around 4% year-to-date, marking its first first-quarter drop in six years as mining economics weaken.
Brie Carter
TV Presenter & Finance EditorTV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.
Contact
Contact editorial teamArticles by Brie Carter
Cryptocurrency
Bitcoin holds $65,200 as Iran war risk spreads
Bitcoin held the $65,200 level and rebounded to $67,402 after falling to $65,112 on Monday, marking its weakest point since the February selloff linked to the Iran war escalation.
Technology
CBAK Energy revenue surges 131% in Q4 on battery demand spike
CBAK Energy Technology (NASDAQ:CBAT), a global manufacturer of lithium-ion rechargeable batteries, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.
Health
Alterity Therapeutics gains FDA alignment for Phase 3 trial
Alterity Therapeutics (ASX:ATH) announced alignment with the US Food and Drug Administration following a pivotal Type C meeting.
Red Mountain defines high-priority antimony drill targets
Red Mountain Mining (ASX:RMX) announced a breakthrough at its 100% owned Armidale Antimony-Gold Project in New South Wales.
Cobalt Blue and Glomar launch US critical minerals consortium
Cobalt Blue (ASX:COB) and US-based Glomar Minerals have announced the formation of a strategic consortium known as Project Infinity.
Cryptocurrency
Bitcoin holds range as market shows signs of pause not reversal
Bitcoin continues to trade within a defined range between $65,000 and $70,000 after facing rejection near the $76,000 level.
Financial
XBP Global posts $1.1B net income in transition year following BPA merger
XBP Global (NASDAQ:XBP) characterized 2025 as a transformative "transition year," reporting full-year results that reflect the significant structural impact of its July 2025 acquisition of BPA.
Eikon Therapeutics reports 2025 financial results and clinical pipeline progress
Eikon Therapeutics (NASDAQ:EIKN), a clinical-stage biotechnology company focused on developing novel medicines through advanced imaging and machine learning platforms, reported corporate and clinical updates on March 30, 2026, alongside its full-year 2025 financial results.
Energy
Terrestrial Energy strengthens US footprint with site selection and $292M capital raise
Terrestrial Energy (NASDAQ:IMSR), a developer of Generation IV advanced nuclear technology, today announced its financial results and program milestones for the fourth quarter and full year ended December 31, 2025.